FDA, NIH, Drugmakers and Nonprofits Launch Gene Therapy Consortium for Rare Diseases

The FDA has teamed up with the National Institutes of Health (NIH), 10 pharmaceutical companies and five nonprofit organizations to launch the Bespoke Gene Therapy Consortium to accelerate development of gene therapies for rare diseases.
Source: Drug Industry Daily